These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13446082)

  • 1. [Significance of cholinesterase; pharmacological activity of a specific inhibitor of true cholinesterase: CT-3318].
    ZANDA CE
    Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1445-7. PubMed ID: 13446082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of cholinesterase inhibition by in vitro manifestation of various effects of a specific inhibitor, bis(2,3-dihydro-2-piperidinomethy1-5-benzofuranyl) ketone dimethiodide (CT-3318)].
    ZANDA CE
    Arch Int Pharmacodyn Ther; 1959 May; 120(1):53-63. PubMed ID: 13662037
    [No Abstract]   [Full Text] [Related]  

  • 3. [Independence of the effects of a selective acetylcholinesterase inhibitor (CT 3318) on striated muscle from its antienzymatic activity].
    GESSA GL; SANGIORGI G
    Boll Soc Ital Biol Sper; 1959 May; 35(9):506-9. PubMed ID: 13662448
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of a quaternary cholinesterase inhibitor, phospholine, and its tertiary analogue, compound 217-AO, on central control of respiration and on neuromuscular transmission: the antagonism by 217-AO of the respiratory arrest caused by morphine.
    SCHAUMANN W; JOB C
    J Pharmacol Exp Ther; 1958 Jun; 123(2):114-20. PubMed ID: 13550065
    [No Abstract]   [Full Text] [Related]  

  • 5. An investigation of the structure-activity correlations within a series of ambenonium analogs.
    LANDS AM; HOPPE JO; ARNOLD A; KIRCHNER FK
    J Pharmacol Exp Ther; 1958 Jun; 123(2):121-7. PubMed ID: 13550066
    [No Abstract]   [Full Text] [Related]  

  • 6. [UBREDTID AND CONSTIPATION, CAPACITY AND TONICITY OF THE COLON UNDER THE INFLUENCE OF A CHOLINESTERASE INHIBITOR].
    DEIMER E; PARTILLA H
    Wien Klin Wochenschr; 1963 Dec; 75():927-9. PubMed ID: 14108933
    [No Abstract]   [Full Text] [Related]  

  • 7. [RESPIRATORY AND CIRCULATORY EXAMINATIONS USING A CHOLINESTERASE INHIBITOR].
    KIESEWETTER E
    Wien Klin Wochenschr; 1965 Mar; 77():158-60. PubMed ID: 14309378
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of 5-hydroxytryptamine by the true-cholinesterase inhibitor 284C51.
    ROBERTSON PA
    J Physiol; 1954 Jul; 125(1):37-8P. PubMed ID: 13192799
    [No Abstract]   [Full Text] [Related]  

  • 9. [Potentiation of the barbital narcosis in mice using cholinmimetic and cholinesterase blockers].
    Oelszner W; Ebert W; Westermann KH
    Acta Biol Med Ger; 1971; 27(5):983-93. PubMed ID: 5148781
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the duration of the anticholinesterase activity of some organic phosphate compounds].
    DONSKAIA LV; KHAUNINA RA
    Biull Eksp Biol Med; 1961 Nov; 52():69-72. PubMed ID: 13887271
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidotes and potentiating agents for phospholine iodide.
    LEHMAN RA; FITCH HM; BLOCHI LP; JEWELL HA; NICHOLLS ME
    J Pharmacol Exp Ther; 1960 Mar; 128():307-17. PubMed ID: 14415357
    [No Abstract]   [Full Text] [Related]  

  • 12. Parasympathomimetics and anticholinesterases.
    BERGEL F
    J Pharm Pharmacol; 1951 Jul; 3(7):385-99. PubMed ID: 14851209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oksazil--a preparation for the treatment of myasthenia and other movement disorders].
    MEDVEDEV BA
    Med Prom SSSR; 1962 May; 5():54-6. PubMed ID: 14472022
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylcholinesterase inhibitory activities of muscarine and muscarone derivatives.
    WITKOP B; DURANT RC; FRIESS SL
    Experientia; 1959 Aug; 15():300-1. PubMed ID: 13845452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nivalin and its curative effect on disease of the nervous system].
    PERNOV KG
    Psychiatr Neurol Med Psychol (Leipz); 1961 Nov; 13():416-20. PubMed ID: 14485457
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticholinesterases in anesthesiological practice].
    MODUGNO V; CANNATA F
    Minerva Anestesiol; 1957 Aug; 23(8):205-14. PubMed ID: 13516521
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of various drugs on metabolism of skeletal muscles. 3. Effect of cholinergic, cholinesterase inhibitor and neuromuscular blocking agents on oxygen consumption of the skeletal musscles].
    Morikawa M
    Nihon Yakurigaku Zasshi; 1973 Mar; 69(2):335-41. PubMed ID: 4807884
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral and bronchial fluids in poisoning with anticholinesterases.
    CULLUMBINE H; DIRNHUBER P
    J Pharm Pharmacol; 1955 Sep; 7(9):580-5. PubMed ID: 13264070
    [No Abstract]   [Full Text] [Related]  

  • 19. [TREATMENT OF POSTOPERATIVE INTESTINAL ATONY WITH UBRETID].
    ROPPOLT H; NEUGEBAUER G
    Wien Klin Wochenschr; 1965 Apr; 77():269-70. PubMed ID: 14311480
    [No Abstract]   [Full Text] [Related]  

  • 20. [MANAGEMENT OF CHRONIC CONSTIPATION WITH ANTICHOLINESTERASES].
    PARTILLA H; DEIMER E
    Wien Klin Wochenschr; 1964 Jun; 76():488-90. PubMed ID: 14236489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.